Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Net Income | -627.20K | -811.20K | -549.00K | -386.40K | 114.80K |
| Total Depreciation and Amortization | 45.40K | 45.40K | 45.40K | 33.60K | 48.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | 10.30K | -- |
| Total Other Non-Cash Items | -176.40K | 411.50K | 485.90K | -1.90M | 1.21M |
| Change in Net Operating Assets | 47.70K | 64.60K | 5.10K | 1.57M | -973.30K |
| Cash from Operations | -710.60K | -289.80K | -12.70K | -669.00K | 403.90K |
| Capital Expenditure | 0.00 | -7.50K | -- | 24.10K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 300.00 | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -7.10K | -- | 24.10K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 2.50K | -1.90K | -6.40K | 18.70K | -8.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -708.10K | -298.80K | -19.00K | -626.20K | 395.20K |